Follow
Smitha Krishnan
Smitha Krishnan
Massachusetts General Hospital-Harvard Medical School
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages
S Krishnan, Y Ding, N Saedi, M Choi, GV Sridharan, DH Sherr, ...
Cell reports 23 (4), 1099-1111, 2018
4962018
Pathways and functions of gut microbiota metabolism impacting host physiology
S Krishnan, N Alden, K Lee
Current opinion in biotechnology 36, 137-145, 2015
1872015
Biologically consistent annotation of metabolomics data
N Alden, S Krishnan, V Porokhin, R Raju, K McElearney, A Gilbert, K Lee
Analytical chemistry 89 (24), 13097-13104, 2017
512017
Advanced MRI of liver fibrosis and treatment response in a rat model of nonalcoholic steatohepatitis
IY Zhou, V Clavijo Jordan, NJ Rotile, E Akam, S Krishnan, G Arora, ...
Radiology 296 (1), 67-75, 2020
202020
THU-093-The calpain inhibitor, BLD-2660, has robust anti-fibrotic activity in a rat model of non-alcoholic steatohepatitis
M Sojoodi, S Krishnan, AA Razavi, MR Day, G Arora, S Goshal, S Li, ...
Journal of Hepatology 70 (1), e201-e202, 2019
42019
Microbiota metabolites derived from tryptophan modulate macrophage inflammation and migration through AMP-activated protein kinase
Y Ding, S Krishnan, RC Alaniz, K Lee, A Jayaraman
The Journal of Immunology 200 (1_Supplement), 53.18-53.18, 2018
12018
Gut Microbiota Metabolites Modulate Inflammation in Non-Alcoholic Fatty Liver Disease
S Krishnan
Tufts University, 2018
12018
Erratum: Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages (Cell Reports (2018) 23 (4)(1099–1111),(S2211124718304856 …
S Krishnan, Y Ding, N Saeidi, M Choi, GV Sridharan, DH Sherr, ...
Cell Reports 28 (12), 3285, 2019
2019
THU-084-A comparative study of anti-Fibrotic therapeutics using aptamer-based quantitative proteomics in a rat model of non-alcoholic steatohepatitis cirrhosis
S Krishnan, S Goshal, S Dillon, R Masia, D Ferreira, P Caravan, Y Li, ...
Journal of Hepatology 70 (1), e196-e197, 2019
2019
Microbiota metabolites derived from tryptophan modulate macrophage inflammation and migration in non-alcoholic fatty liver disease
Y Ding, S Krishnan, K Lee, A Jayaraman
The Journal of Immunology 198 (1_Supplement), 197.14-197.14, 2017
2017
Understanding and overcoming process insults through application of ‘omics technologies
A Gilbert, K McElearney, S Krishnan, N Alden, WI Yang, K Lee, ...
2016
Identification of gut microbiota-derived metabolites as liver inflammation modulators in non-alcoholic fatty liver disease
S Krishnan, M Choi, Y Ding, N Saedi, ML Yarmush, A Jayaraman, K Lee
Food, Pharmaceutical and Bioengineering Division 2015-Core Programming Area …, 2015
2015
13C Metabolic Flux Analysis to Study the Effect of Oxygen on Cellular Metabolism of A549 and HeLa Cell Lines
S Krishnan
Johns Hopkins University, 2013
2013
MRI Relaxometry in a Rat Model of Nonalcoholic Steatohepatitis (NASH)
IY Zhou, N Rotile, VC Jordan, G Arora, S Krishnan, H Slattery, N Warner, ...
Multi-Parametric MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis (NASH)
IY Zhou, VC Jordan, N Rotile, S Krishnan, H Krishnan, G Arora, H Slattery, ...
Imaging response to Elafibranor treatment in a rat model of non-alcoholic steatohepatitis non-invasively by oxidized-collagen molecular MRI
VC Jordan, IY Zhou, N Rotile, N Warner, EA Akam, G Arora, S Krishnan, ...
The system can't perform the operation now. Try again later.
Articles 1–16